Menopausal stage differences in endothelial resistance to ischemia‐reperfusion injury

Abstract Background In postmenopausal women, reduced ovarian function precedes endothelial dysfunction and attenuated endothelial resistance to ischemia‐reperfusion (IR) injury. We hypothesized that IR injury would lower endothelial function, with premenopausal women demonstrating the greatest prote...

Full description

Bibliographic Details
Main Authors: Jocelyn M. Delgado Spicuzza, David N. Proctor, Dick H. J. Thijssen, Yasina B. Somani
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Physiological Reports
Subjects:
Online Access:https://doi.org/10.14814/phy2.15768
Description
Summary:Abstract Background In postmenopausal women, reduced ovarian function precedes endothelial dysfunction and attenuated endothelial resistance to ischemia‐reperfusion (IR) injury. We hypothesized that IR injury would lower endothelial function, with premenopausal women demonstrating the greatest protection from injury, followed by early, then late postmenopausal women. Methods Flow‐mediated dilation (FMD) was assessed at baseline and following IR injury in premenopausal (n = 11), early (n = 11; 4 ± 1.6 years since menopause), and late (n = 11; 15 ± 5.5 years since menopause) postmenopausal women. Results There were significant group differences in baseline FMD (p = 0.007); post hoc analysis revealed a similar resting FMD between premenopausal (7.8% ± 2.1%) and early postmenopausal (7.1% ± 2.7%), but significantly lower FMD in late postmenopausal women (4.5% ± 2.3%). Results showed an overall decline in FMD after IR injury (p < 0.001), and a significant condition*time interaction (p = 0.048), with early postmenopausal women demonstrating the most significant decline in FMD following IR. Conclusion Our findings indicate that endothelial resistance to IR injury is attenuated in healthy early postmenopausal women.
ISSN:2051-817X